Participant
Nixon Peabody LLP
Paid on 2 local government issues in BRB's local issuance fee table, $18,880 in fees reported.
By role
| Role? | Issues? | Par of those issues? | Fees paid? | Median cost per $1,000? | Negotiated? | Competitive? | Private placement? | First FY? | Last FY? | Paid by the underwriter? |
|---|---|---|---|---|---|---|---|---|---|---|
| RoleOther counsel | Issues2 | Par of those issues$11,830,000 | Fees paid$18,880 | Median cost per $1,000$1.62 | Negotiated1 | Competitive0 | Private placement1 | First FY2021 | Last FY2022 | Paid by the underwriter$0 |
Issues
2 issues, newest first.
Skip the issues nixon peabody llp worked on table| Issue? | Issuer? | Closed? | FY? | Role? | Sale type? | Par? | Fees to this firm? | Per $1,000 of par? |
|---|---|---|---|---|---|---|---|---|
| Ltd Tax GO Ref Bonds Ser 2022 | Parmer County Hospital District | 1/26/2022 | 2022 | Other counsel | Private placement | $6,765,000 | $10,000 | $1.48 |
| Spec Assessment Rev Bonds Ser 2021 (Trails at Cottonwood Creek PID Major Impr Area Proj) | Rowlett | 6/10/2021 | 2021 | Other counsel | Negotiated | $5,065,000 | $8,880 | $1.75 |
| Total, all 2 | $18,880 |
- Closed
- 1/26/2022
- FY
- 2022
- Role
- Other counsel
- Sale type
- Private placement
- Par
- $6,765,000
- Fees to this firm
- $10,000
- Per $1,000 of par
- $1.48
Spec Assessment Rev Bonds Ser 2021 (Trails at Cottonwood Creek PID Major Impr Area Proj)
- Closed
- 6/10/2021
- FY
- 2021
- Role
- Other counsel
- Sale type
- Negotiated
- Par
- $5,065,000
- Fees to this firm
- $8,880
- Per $1,000 of par
- $1.75
Rows 1–2 of 2
Fees are as BRB's table reports them for each issue. The underwriter's spread counts once, and median and per-$1,000 figures use the issuer's one-time costs only: rows paid by the underwriter are shown in the fees but not added to them (how the participant tables are made).
EMMA links are added as each issue is matched.
Source: Local Issuance Fee By Year (updated by the publisher 10/6/2026). Loaded here 10/9/2026.
Texas fiscal years run September 1 to August 31.
Issuer names are shown as published, without source footnote letters.
Figures are as reported to the agency and have not been independently verified.
